Acute exacerbations of COPD and risk of lung cancer in COPD patients with and without a history of asthma.

COPD asthma exacerbations lung cancer

Journal

European clinical respiratory journal
ISSN: 2001-8525
Titre abrégé: Eur Clin Respir J
Pays: United States
ID NLM: 101662134

Informations de publication

Date de publication:
07 Aug 2020
Historique:
entrez: 18 9 2020
pubmed: 19 9 2020
medline: 19 9 2020
Statut: epublish

Résumé

There is limited knowledge on the effect of acute exacerbations in chronic obstructive pulmonary disease (AECOPD) on lung cancer risk in COPD patients with and without a history of asthma. This study aims to examine whether AECOPD is associated with risk of lung cancer, and whether the effect depends on a history of asthma. In the GenKOLS study of 2003-2005, 852 subjects with COPD performed spirometry, and filled out questionnaires on smoking habits, symptoms and disease history. These data were linked to lung cancer data from the Cancer Registry of Norway through 2013. AECOPD, measured at baseline was the main predictor. To quantify differences in lung cancer risk, we performed Cox-proportional hazards regression. We adjusted for sex, age, smoking variables, body mass index, and lung function. During follow-up, 8.8% of the subjects with, and 5.9% of the subjects without exacerbations were diagnosed with lung cancer. Cox regression showed a significant increased risk of lung cancer with one or more exacerbations in COPD patients without a history of asthma, HRR = 2.77 (95% CI 1.39-5.52). We found a significant interaction between a history of asthma and AECOPD on lung cancer. AECOPD is associated with an increased risk of lung cancer in COPD patients without a history of asthma.

Identifiants

pubmed: 32944202
doi: 10.1080/20018525.2020.1799540
pii: 1799540
pmc: PMC7480432
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1799540

Informations de copyright

© 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

Déclaration de conflit d'intérêts

No potential conflict of interest was reported by the authors.

Références

Lung Cancer. 2015 Nov;90(2):121-7
pubmed: 26363803
Chest. 2003 Aug;124(2):474-81
pubmed: 12907531
N Engl J Med. 2007 Feb 22;356(8):775-89
pubmed: 17314337
Am J Respir Crit Care Med. 2015 May 15;191(10):1166-75
pubmed: 25760561
Nat Rev Cancer. 2010 Dec;10(12):878-89
pubmed: 21102637
Thorax. 2017 Sep;72(9):825-831
pubmed: 28377492
COPD. 2018 Feb;15(1):27-35
pubmed: 29257905
Curr Opin Pulm Med. 2015 Jan;21(1):74-9
pubmed: 25405671
Int J Chron Obstruct Pulmon Dis. 2015 Jul 27;10:1443-54
pubmed: 26251584
Chest. 2018 Jun;153(6):1326-1335
pubmed: 29452098
Eur Respir J. 2009 Oct;34(4):858-65
pubmed: 19324952
N Engl J Med. 2011 Aug 4;365(5):395-409
pubmed: 21714641
Am J Respir Crit Care Med. 2003 Feb 1;167(3):418-24
pubmed: 12426229
Am J Respir Crit Care Med. 2006 Apr 1;173(7):736-43
pubmed: 16424444
Biosci Rep. 2019 May 14;39(5):
pubmed: 31015366
Int J Chron Obstruct Pulmon Dis. 2018 Jun 06;13:1833-1839
pubmed: 29922050
Int J Chron Obstruct Pulmon Dis. 2018 Oct 12;13:3341-3348
pubmed: 30349237
Am J Respir Crit Care Med. 2007 Apr 1;175(7):712-9
pubmed: 17185647
Eur Respir J. 2017 May 11;49(5):
pubmed: 28495686
Circulation. 2016 Feb 9;133(6):601-9
pubmed: 26858290
PLoS One. 2015 Sep 03;10(9):e0136065
pubmed: 26336076
Clin Sci (Lond). 2019 Jul 25;133(14):1663-1703
pubmed: 31346069
Eur Radiol. 2016 Nov;26(11):3821-3829
pubmed: 26868497
Clin Physiol. 2001 Nov;21(6):648-60
pubmed: 11722472
Ann Am Thorac Soc. 2015 Jun;12(6):813-20
pubmed: 25822654
Gastroenterology. 2016 Jan;150(1):64-78
pubmed: 26385073
Respirology. 2010 Apr;15(3):536-42
pubmed: 20415983
PLoS One. 2012;7(5):e37483
pubmed: 22624038
Thorax. 2008 Sep;63(9):761-7
pubmed: 18728201
Respir Med. 2019 Jun;152:81-88
pubmed: 31128615
Respiration. 2011;81(4):265-84
pubmed: 21430413
Eur J Cancer. 2009 May;45(7):1218-1231
pubmed: 19091545
Respir Med. 2013 Aug;107(8):1222-33
pubmed: 23768737
Eur Respir J. 2006 Dec;28(6):1245-57
pubmed: 17138679
Am J Respir Crit Care Med. 1995 Nov;152(5 Pt 2):S77-121
pubmed: 7582322
N Engl J Med. 2009 Dec 3;361(23):2221-9
pubmed: 19955524
Respir Med. 2009 Jan;103(1):85-90
pubmed: 18793832
Lung Cancer. 2006 Jul;53(1):5-12
pubmed: 16733074
Arch Bronconeumol. 2012 Mar;48(3):86-98
pubmed: 22196477
J Thorac Oncol. 2015 Jun;10(6):890-6
pubmed: 25783198
N Engl J Med. 1999 Jun 24;340(25):1948-53
pubmed: 10379018
Respirology. 2017 Jan;22(1):61-70
pubmed: 27761973
Ann Am Thorac Soc. 2017 Mar;14(3):392-402
pubmed: 28076701
Int J Chron Obstruct Pulmon Dis. 2017 Mar 27;12:1009-1018
pubmed: 28392685
N Engl J Med. 2008 Nov 27;359(22):2355-65
pubmed: 19038881
COPD. 2014 Apr;11(2):163-70
pubmed: 24111662

Auteurs

Ane Aamli Gagnat (AA)

Department of Clinical Science, University of Bergen, Bergen, Norway.

Miriam Gjerdevik (M)

Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.

Stein Atle Lie (SA)

Department of Clinical Dentistry, University of Bergen, Bergen, Norway.

Amund Gulsvik (A)

Department of Clinical Science, University of Bergen, Bergen, Norway.

Per Bakke (P)

Department of Clinical Science, University of Bergen, Bergen, Norway.

Rune Nielsen (R)

Department of Clinical Science, University of Bergen, Bergen, Norway.
Department of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway.

Classifications MeSH